Agents stabilizing G-quadruplexes have the potential to destroy the functional structure of telomere and could therefore act as antitumor agents. We previously reported that SYUIQ-5 could stabilize G-quadruplex, induce senescence, and inhibit c-myc gene promoter activity. In this study, we showed that SYUIQ-5 inhibited proliferation of CNE2 and HeLa cancer cells, triggered a rapid and potent telomere DNA damage response characterized by the formation of telomeric foci γ-H2AX, and obviously induced autophagy with the features of increased LC3-II and a punctuated pattern of YFP-LC3 fluorescence. These phenomena may primarily depend on the delocalization of TRF2 from telomere, which was further degraded by proteasomes. Furthermore, overexpression of TRF2 inhibited SYUIQ-5-induced γ-H2AX expression. Also, ATM was activated following SYUIQ-5 treatment. The pretreatment with ATM inhibitor ku55933 and ATM siRNA effectively reduced the production of γ-H2AX and LC3-II. ATM knockdown partially antagonized the anticancer effects of SYUIQ-5. Moreover, inhibition of autophagy by short hairpin RNA against the autophagy-related gene ATG5 attenuated the cytotoxicity of SYUIQ-5. These results indicated that SYUIQ-5 triggered potent telomere damage through TRF2 delocalization from telomeres, and eventually induced autophagic cell death in cancer cells. Our findings exhibit a novel mechanism that is responsible for the antitumor effects of SYUIQ-5. [Mol Cancer Ther 2009;8 (12):3203-13] 
Introduction
Human telomeric DNA protects the chromosome ends from degradation, recombination, and inappropriate DNA repair activities (1, 2) . In addition to the terminal ssDNA sequence, most telomeres contain several kilobases of double-stranded TTAGGG repeats in mammals (3) . This repetitive DNA contributes to a unique "t-loop" and D-loop" sealed by an insertion of the G-rich 3′-overhang sequences into duplex DNA (4), involved in telomere protection. The G-rich strand may also adopt particular conformation such as G-quadruplexes. Ligands that selectively bind to and stabilize G-quadruplexes structures may interfere with telomere conformation and telomere elongation, making these compounds attractive anticancer agents. In addition, some proteins are involved in protecting telomere extremities and make up a complex called the telosome (5) or shelterin (6) . A crucial way in which shelterin is thought to affect the structure of telomeric DNA is by forming t-loops. This complex is composed of six proteins including TRF1 (7, 8) , TRF2 (9), POT1 (10), TIN2 (11) , TPP1 (12) , and Rap1 (13) . TRF2 binds directly to the tandem array of duplex TTAGGG repeats and coats the length of all human telomeres at all stages of the cell cycle (9, 14) . In addition to telomere attrition, more recent experiments suggest that telomere deprotection can also be induced by the loss of function of double stranded telomere-binding proteins at the telomere. TRF2-depleted telomeres are perceived as if they represent sites of DNA damage (15) . TRF2
ΔBΔM , a dominant negative mutant of TRF2 lacking the basic/myb domain, binds the endogenous TRF2 and forms an inactive heterodimer unable to bind telomere DNA, and serves as a TRF2 inhibitor and DNA double-strand breaks inducer (16) .
Many DNA damage response proteins, including ATM, are thought to participate in telomere maintenance. ATM is principally activated following DNA double-strand breaks by autophosphorylation of its residue serine 1981 and leads to the phosphorylation of multiple downstream proteins involved in DNA damage recognition, cell cycle checkpoints, and apoptosis, such as p53, H2AX, CHK2, and SMC1 (17) . It has also been reported to be the main transducer of the telomere damage signal due to telomere attrition during senescence or TRF2 inhibition (18) . Telomeres rendered dysfunctional by the removal of TRF2 are recognized as DNA double-strand breaks and then activate ATM (19) .
G-quadruplex structures have recently attracted more attention due to an increasing recognition of the significant role they play in the biology of tumors; they therefore provide a new and potentially important target for drug development. Several classes of small molecules have been identified to interact with and stabilize G-quadruplexes, including tricyclic anthraquinones (20) , fluorenones (21), substituted acridines (22, 23) , cationic porphyrins (24, 25) , telomestatin (SOT-095; ref. 26 ), a perylenetetracarboxylic diimide derivative (27) , indoloquinolines (28) , pyridinedicarboxamide derivatives (29) , and a benzonaphthofurandione tetracyclic compound (30) . Cryptolepine is a naturally occurring quindoline alkaloid. Cryptolepine is also a rare example of natural product whose preparation was reported before its isolation from natural resource. Recent studies have revealed that some structural derivatives of cryptolepine were capable of interacting with G-quadruplex forms of DNA and inhibiting the activity of telomerase (28, 31) .
Our previous studies showed that SYUIQ-5, a Cryptolepine derivative, could induce and stabilize G-quadruplexes (32) . Long-term exposure of cells to low concentrations of SYUIQ-5 caused senescence and telomere shortening (33) . Also, we found that SYUIQ-5 inhibited c-myc promoter and telomerase activity in cancer cells (34) . However, under higher concentrations, SYUIQ-5 rapidly limited cell growth. This suggested that additional mechanisms may explain the biological activity of the ligands in tumor cell lines. In the current study, we have found that SYUIQ-5 delocalized TRF2 from telomeres, resulting in a rapid and potent DNA damage response, induced autophagy with the features of LC3-II increase. We have also shown that SYUIQ-5-induced autophagy plays an important role in the antitumor activities of this compound.
Materials and Methods

Cell Culture and Regents
The human cervix cancer cell line HeLa and nasopharyngeal carcinoma cell line CNE 2 were cultivated in RMPI 1640 medium supplemented with 10% fetal bovine serum in a 5% CO 2 humidified atmosphere at 37°C. Anti-TRF1, actin, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and second antibodies were purchased from Santa Cruz Biotechnology. Phospho-H2AX (γ-H2AX), phospho-Chk2 (Thr68), ATM, myc-tag, ATG5, TRF2, and chemiluminescence reagents were obtained from Cell Signaling. Phospho-ATM was purchased from Upstate Biotechnology, and anti-LC3 was obtained from Novus Biologicals. DMSO, 4,6-diamidine-2-phenylindole, MTT, monodansylcadaverine (MDC) were purchased from Sigma. MG132 was purchased from Beyotime. Ku55933 was purchased from Calbiochem. Lipofectamine 2000, goat anti-rabbit Alexa 488, and goat anti-mouse Alexa 680 were obtained from Invitrogen Corporation.
Immunofluorescence For these experiments, the coverslips with 13mm×13mm were placed in the wells of a 24-well plate and cells were subcultured into a 24-well plate. After treatment, cells were fixed with PBS containing 4% paraformaldehyde for 20 min and permeabilized with 0.25% TritonX-100 in PBS for 10 min at room temperature. After washing thrice with PBS, coverslips were treated with blocking buffer (PBS + 0.1%Tween + 1% bovine serum albumin) for 1 h. For immunolabeling experiments, cells were incubated with the primary antibody, then washed and incubated with goat anti-rabbit Alexa 488 and/or goat anti-mouse Alexa 680. Nuclei were visualized using 4,6-diamidine-2-phenylindole (Sigma-Aldrich). Cells in coverslips were observed using confocal microscopy.
Constructs, Retroviral Infection, and Transfection For stable ATG5 siRNA expression, the retroviral vector (pSUPER. puro, a gift of Professor Musheng Zeng, Cancer Center, Sun Yat-sen University, Guangzhou, China) encoding hairpin RNA sequences was constructed. Two distinct short hairpin RN (shRNA) sequences against ATG5 (shATG5 hp-2, shATG5 hp-7; ref. 35) were generated and cloned into the expression vector. Vesicular stomatitis virus-pseudotyped vectors were produced by transfection of the VSV-GPG producer cell line with 5 μg DNA using Lipofectamine 2000 (Invitrogen) in a six-well plate. Retrovirus-containing supernatants were collected at days 5 to 7 after transfection. Then CNE2 and HeLa cells were infected with retrovirus-containing supernatants thrice. The positive cells stably expressing shATG5 were selected under puromycine (1 μg/mL).
TRF2 and TRF2 ΔBΔM (basic/myb domain defection) plasmids were gifts from Professor JianDing, Shanghai Institute of Materia Medica, Shanghai, China. The vector pCDNA3.1-myc-his (−) was used as control plasmid. For transient transfection, cancer cells were seeded on six-well plates and maintained in culture for 24 h. Then the transfection was done by using Opti-MEM media, lipofectamine 2000 and the indicated plasmid according to manufacturer's recommendations.
For the generation of cell lines stably expressing TRF2, CNE2 and HeLa cells were seeded into six-well plates the day before transfection. Transfections of TRF2 plasmid and control vector were done with Lipofectamine 2000 according to the protocol suggested by the manufacture. After 48 h of transfection, the positive clones were selected under G418 (400 μg/mL for CNE2 and 500 μg/mL for HeLa).
For transient transfection, the siRNA against the sequence 5′-GGGCAAUAUUUCAAAUUAATT-3′ of the human ATM mRNA was synthesized by GenChem Co. For transfection, cancer cells were seeded on six-well plates and maintained in culture for 24 h. Then the transfection was done by using Opti-MEM media, Lipofectamine 2000, and duplex siRNAs according to manufacturer's recommendations. Duplex siRNAs were used at 100 nmol/L final concentration. Twenty-four hours after transfection, the cells were then treated with SYUIQ-5 for Western blotting assay or MTT assay.
MTT Assay Cells were seeded on 96-well plates (CNE2, 4 × 10 3 /well; HeLa, 6 × 10 3 /well) and preincubated for 24 h at 37°C in a humidified atmosphere of 5% CO 2 before exposure to different dilutions of SYUIQ-5. After SYUIQ-5 treatment, 10 μL of MTT (5 mg/mL) were added to each well. The cells were incubated for another 4 h at 37°C, and then the liquid in the wells was evaporated. DMSO (100 μL) was added, and the absorbance (570/655 nm) was measured to estimate cell viability (36) .
MDC Staining
For these experiments, the coverslips with 13mm×13mm were placed in the wells of a 24-well plate and cells were subcultured into a 24-well plate covered with slips. After treatment, cells were fixed with PBS containing 4% paraformaldhyde for 20 min and then washed thrice with PBS. Autophagosomes were labeled with MDC as previously described (37) .
Assessment of the Involvement of LC3 Cells were transiently transfected with the yellow fluorescent protein (YFP)-tagged LC3 expression vector using Lipofectamine 2000. After being cultured for 24 h, cells were treated with 0.1%DMSO or SYUIQ-5. For the 24-h treatment as described above, the cells were fixed with 4% paraformaldehyde and examined under a fluorescence microscope. To quantify autophagic cells after treatment, we counted the number of autophagic cells (≥5 YFP-LC3 dots per cell) among >80 YFP-positive cells per time point in three independent experiments.
Primers and Reverse Transcription Polymerase Chain Reaction
The primers used for detecting TRF1 and TRF2 mRNA were as follows: TRF1, 5′-TCTCTCTTTGCCGAGCTTTCC-3′ (sense) and 5′-ACTGGCAAGCTGT TAGACTGGAT-3′ (antisense)'; TRF2 primers used were 5′-TCCCAAAGTACC CAAAGGC-3′ (sense) and 5′-ACTCCAGCCTTGACC-CACTC-3′ (antisense); GAPDH was used as the loading control with the primers of 5′-TCACCA TCT TCC AGG AGC GAG A-3′ (sense) and 5′-GCA GGA GGC ATT GCTGAT GAT C-3′ (antisense). Cells were treated with the indicated conditions, and then the total RNA was isolated by TRIzol (Invitrogen) according to the manufacturer's instructions. The reverse transcription polymerase chain reaction reactions were done as previously described (38) .
Immunoblotting Analysis Cells were harvested and lysed in lysis buffer [20 mmol/L Na 2 PO 4 (pH 7.4), 150 mmol/L NaCl, 1% Triton X-100, 1% aprotinin, 1 mmol/L phenymethysulfonyl fluoride, 10 mg/mL leupeptin, 100 mmol/L NaF, and 2 mmol/L Na 3 VO 4 ]. Twenty to~40 μg of total proteins were separated by SDS-PAGE transferred to polyvinylidene difluoride membranes, and analyzed by immunoblotting using the enhanced chemiluminescence (Amersham) method.
Statistical Analysis Data are mean ± SD. The significance of the in vitro experiments was determined using the Student's t test (two tailed). P values of ≤0.05 were considered statistically significant.
Results
SYUIQ-5 Inhibited Proliferation and Induced Autophagy in CNE2 and HeLa Cancer Cells
Cell viability was determined in a 3-day cytotoxic assay using various concentrations of SYUIQ-5. SYUIQ-5 treatment significantly decreased the cell viability of CNE2 and HeLa cells in a dose-dependent manner. The IC 50 values of SYUIQ-5 for CNE2 and HeLa cells were 0.9322 and 0.5508 μg/mL, respectively (Fig. 1A) . A recent investigation showed that the amount of LC3-II is associated with autophagy induction. Western blot analysis with anti-LC3 antibody revealed that the expression of LC3-I and LC3-II proteins markedly increased in CNE2 and HeLa cells treated with SYUIQ-5 in a dose-dependent manner compared with DMSO (0.1%) treatment (Fig. 1B) . It suggested that SYUIQ-5 induced the synthesis of LC3 protein and the conversion of a substantial fraction of LC3-I into LC3-II. In addition, the SYUIQ-5-treated group showed higher fluorescent density and more MDC-labeled particles in CNE2 and HeLa cells compared with the control group (Fig. 1C) .
Moreover, the presence of a punctate pattern of YFP-LC3 expression (YFP-LC3 dots) was assessed to determine whether LC3 is concentrated in CNE2 and HeLa cancer cells by SYUIQ-5. YFP-LC3 expression vector were transiently transfected into CNE2 and HeLa cells for 24 h, then the cells treated with SYUIQ-5(2 μg/mL) or DMSO (0.1%) for an addition 24 h. The distribution of YFP-LC3 was detected by fluorescent microscopy. The YFP-LC3-transfected CNE2 and HeLa cells showed diffuse distribution of YFP-LC3 in the presence of DMSO, whereas SYUIQ-5-treated cells showed a marked increase in number and frequency of YFP-LC3 dots (≥5 dots per cell; Fig. 1D, top) . This YFP fluorescence pattern indicated that LC3 was recruited to autophagic vacuoles and represented the presence of autophagy in both tumor cell lines treated with SYUIQ-5. To quantify the induction of cells expressing YFP-LC3 dots, we counted >80 YFP-positive cells for each treatment. As shown in Fig. 1D (bottom) , 71.7% of CNE2 cells and 67.2% of HeLa cells treated with SYUIQ-5 at 2 μg/mL for 24 h showed YFP-LC3 dots, whereas these autophagic features were detected in only 21.1% of DMSO-treated CNE2 cells and 15.9% of DMSO-treated HeLa cells. The number of cells expressing YFP-LC3 in a punctate pattern was significantly increased in CNE2 and HeLa cells treated with SYUIQ-5 compared those treated with 0.1% DMSO (P < 0.001). All these results suggested that CNE2 and HeLa cells underwent autophagy when stimulated by SYUIQ-5.
TRF2 Rapidly Delocalized from Telomeres after SYUIQ-5 Treatment
To study the mechanism of autophagy induced by SYUIQ-5, telomere binding protein TRF1 and TRF2 were detected at protein and mRNA levels under indicated concentrations of SYUIQ-5. In the presence of 0.5 to 4 μg/mL SYUIQ-5, a strong reduction of TRF2 protein levels was observed in a dose-dependent manner, whereas TRF1 had no fundamental changes (Fig. 2A) . The mRNA levels of TRF1 and TRF2 were examined by reverse transcription-PCR. The results manifested that SYUIQ-5 did not significantly alter the abundance of the mRNAs of TRF1 and TRF2 in CNE2 and HeLa cancer cells. These indicated that SYUIQ-5 posttranscriptionally affected TRF2 expression (Fig. 2B) .
To further address the behavior of TRF2 in this process, double immunofluorescence was used to test the relationship between TRF2 and TRF1(a good marker for interphase telomeres; ref. 39 ) under the observation of confocal microscopy. In 0.1% DMSO-treated cells, the images of merged TRF1 (red) and TRF2 (green) staining were observed. However, in SYUIQ-5-treated cells, the fluorescence intensity of TRF2 reduced and most of them delocalized from TRF1 position. These results showed that SYUIQ-5 rapidly removed TRF2 from TRF1 foci (Fig. 2D) . TRF2 proteins decreased after SYUIQ-5 treatment, but TRF2 mRNA had no change. It indicated that the reduction of this protein by SYUIQ-5 could be due to its degradation. MG-132, a proteasome inhibitor, blocked TRF2 degradation by SYUIQ-5 (Fig. 2C) . These data suggested that TRF2 proteins were degraded by proteasomes when delocalized from telomeres after SYUIQ-5 treatment.
Telomere DNA Damage Induced by SYUIQ-5
To investigate the consequence of TRF2 delocalization on telomeres, CNE2 and HeLa cells were used to detect whether the telomeres were uncapped in SYUIQ-5 exposure. CNE2 and HeLa cells were treated with 0.1% DMSO or 2 μg/mL SYUIQ-5 for 48 hours. The results showed that H2AX was markedly phosphorylated on serine 139 (called γ-H2AX) in SYUIQ-5-treated cells (Fig. 3A) . Moreover, immunofluorescence experiments were used to detect γ-H2AX foci in CNE2 and HeLa cells exposed to SYUIQ-5 or DMSO. Notably, γ-H2AX foci could be observed in SYUIQ-5-treated cells, 
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whereas there were no detectable foci in the DMSO treatment group (Fig. 3B) . To quantify the cells expressing γ-H2AX foci, we counted >80 cells for each treatment and calculated the proportion of γ-H2AX-positive cells (≥5 dots per cell). As shown in Fig. 3C , 77.5% of CNE2 cells and 90.7% of HeLa cells treated with SYUIQ-5 at 2 μg/mL for 24 hours showed γ-H2AX dots, whereas these DNA damage features were detected in only 9.7% of untreated CNE2 cells and 9.2% of untreated HeLa cells. The number of γ-H2AX-positive cells was significantly increased following SYUIQ-5 treatment compared with DMSO treatment (P < 0.001). These notable differences indicated that SYUIQ-5 was a potent DNA damage inducer. To ascertain whether DNA damage developed in telomeres, double immunofluorescence experiments were done in CNE2 and HeLa cells. Confocal microscopy revealed that most of the γ-H2AX foci induced by SYUIQ-5 colocalized with TRF1 (also used as a telomere marker), forming the telomere dysfunction-induced foci (Fig. 3D) .
Overexpression of TRF2 Prevented SYUIQ-5-Mediated Telomere DNA Damage, Autophagy, and Cell Death
To explore the relationship between TRF2 delocalization and telomere damage, the plasmid encoding wild-type TRF2 or TRF2
ΔBΔM (basic/myb domain defection) or vector plasmid (control) were transiently transfected into CNE2 and HeLa cells by using Lipofectamine 2000. Twenty-four hours later, these cells were incubated in SYUIQ-5 (4 μg/mL) for an additional 24 hours. Then the cells were harvested and lysed. Expression of TRF2 was verified by immunoblotting. The results showed that under SYUIQ-5 treatment, the levels of γ-H2AX and LC3-II decreased in wild-type TRF2 plasmid-transfected cells compared with the vector-transfected cancer cells (Fig. 4A) . However, the cells expressing high levels of TRF2 ΔBΔM showed a more intensive H2AX phosphorylation and stronger LC3-II expression.
To further confirm the role of TRF2 in SYUIQ-5-induced cell death, we transfected CNE2 and HeLa cells with TRF2 or the vector plasmid and established the stable expression cell lines with G-418 selection (Fig. 4B) . The cell viability was determined following 48 hours of exposure to various concentrations of SYUIQ-5. TRF2 overexpressing cancer cells showed lower sensitivity to SYUIQ-5 compared with the control group (Fig. 4C) .
SYUIQ-5 Induced Telomere DNA Damage in an ATMDependent Manner
To further investigate the signal pathway of telomere DNA damage, ATM signaling in CNE2 and HeLa cells was studied. The results showed that SYUIQ-5 significantly induced ATM phosphorylation (serine 1981), accompanied by phosphorylation of H2AX and LC3-II increase (Fig. 5A) . Combination with ku55933, an ATM inhibitor, reduced the expression levels of phospho-Chk2, γ-H2AX, and LC3-II (Fig. 5B) . ATM knockdown by siRNA inhibited the expression of γ-H2AX and LC3-II (Fig. 5C ) and attenuated SYUIQ-5-induced cell death (Fig. 5D) . These results indicated that SYUIQ-5 induced telomere DNA damage and autophagy in an ATM-dependent manner.
SYUIQ-5 Induced Autophagic Cell Death in Cancer Cells
To confirm that SYUIQ-5 induced autophagy-associated cell death, autophagy-defective CNE2 and HeLa cells were established by using shRNA against the autophagy-related gene ATG5 (shATG5). Blockage of the formation of ATG5-ATG12 prevented the generation of autophagosomes (40) . Cells were transfected with two independent shRNA constructs against ATG5 (hp-2 and hp-7) or a control (HC), and then the positive clones were selected using puromycine. Decreased expression levels of ATG5 in cells expressing shATG5 hp-2 (hp-2) and shATG5 hp-7 (hp-7) but not in cells expressing HC was confirmed by Western blot (Fig. 6A) . The decrease of LC3-II in hp-2 and hp-7 cells compared with HC cells indicated that SYUIQ-5-induced autophagy can be partially blocked by ATG5 knockdown (Fig. 6B) . We then determined the cell viability in various concentrations of SYUIQ-5. ATG5 knockdown attenuated SYUIQ-5-mediated cell death (Fig. 6C) . These results indicated that inhibition of cell proliferation and induction of cell death by SYUIQ5 partially depended on autophagy induction.
Discussion
The results described in this study provided evidences that SYUIQ5, a Gquadruplex ligand, potently inhibited the proliferation and induced telomere DNA damage and autophagy in CNE2 and HeLa cancer cells in vitro. TRF2 delocalized from telomeres after SYUIQ5 treatment and was further degraded by proteasomes. In addition, overexpression of TRF2 prevented SYUIQ5-mediated cell death. ATM was also activated and involved in SYUIQ-5-induced telomere DNA damage response and autophagy. Furthermore, ATG5 knockdown attenuated the cytotoxicity of SYUIQ-5 in CNE2 and HeLa cells.
Telomeres are capable of forming guanine quadruplex (G4) structures on the G-rich strand, and the ligands that interact with G-quadruplex are recognized as promising anticancer agents by interfering with telomere conformation and telomere elongation. These compounds were first evaluated as telomerase inhibitors and induced telomere shortening and senescence. Recently, it was observed that G-quadruplex ligands induced a short-term response (cell death) that cannot be explained merely by telomerase inhibition (26, 29, 41) . Thus, these ligands probably have special biological activities as potential antitumor agents (42) . Some research has shown that telomere shortening or the loss of protective factors such as TRF2 and POT1 activated a DNA damage response (15, 43) and elicited cell death. Our previous studies have shown that SYUIQ-5 could interact with and stabilize G-quadruplexes, potentially inducing telomere shortening and cell senescence. In addition, the c-myc promoter and telomerase activity were inhibited following exposure of the cells to low concentrations of SYUIQ-5. However, the mechanism(s) of inducing cell death in 72 hours for SYUIQ-5 is unclear. In this study, we found that telomere damage and autophagy induction were involved in SYUIQ-5-induced cell death.
Autophagy is a process conserved by evolution that allows cells to sequester and degrade cytoplasmic proteins and organelles through the formation of double-membrane -type  TRF2, TRF2 ΔBΔM , or vector plasmid (empty), then the cells treated with SYUIQ-5 (4 μg/mL) for an additional 24 h. Protein levels were detected by immunoblotting assay using anti-TRF2, anti-γ-H2AX, and anti-LC3
antibodies. B, overexpression of TRF2 was verified by anti-myc-tag antibody and anti-TRF2 antibody.
GAPDH serves as a loading control. C, CNE2 and HeLa cells stably expressing TRF2 or vector plasmid were exposed to the indicated concentration of SYUIQ-5 for 48 h. The viability of cells was evaluated by MTT assay. Columns, mean of three independent experiments; bars, SD. P < 0.05 (*) and P < 0.01 (**) compared with vector plasmid.
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Mol Cancer Ther 2009;8 (12) . December 2009 vesicles (autophagosomes) and then recycle these materials (44) . Induction of autophagy has been identified in several conditions, including nutrient deprivation, aging, and chemical and radiation cancer therapy (45) . Whether autophagy induction in treated cancer cells represents a mechanism that allows tumor cells to survive or initiates a nonapoptotic cell death remains uncertain. Accumulated evidences suggest that the magnitude of autophagy may determine the fate of cancer cells. A basic or low level autophagy allows cell survival during stress, however intensive or prolonged autophagy results in cell death. As the results shown above, SYUIQ-5 obviously induced autophagy with the features of increased LC3-II and a punctuated pattern of YFP-LC3 fluorescence. To address the issue whether SYUIQ-5-induced autophagy led cells to survive or die, autophagy-deficient cells were established by knockdown of ATG5. ATG5 knockdown blocks the proximal step of autophagy (40) . The results (Fig. 6) showed that ATG5 knockdown could attenuate SYUIQ-5-induced cell death and indicated that an autophagy-mediated cell killing effect occurs rather than a protective reaction under SYUIQ-5 treatment.
A notable increase of γ-H2AX and the telomere dysfunction-induced foci, which was formed by γ-H2AX and TRF1 colocalization, was detected in SYUIQ-5-treated cells by immunoblotting and immunofluorescence (Fig. 3) , providing evidences that SYUIQ-5 was a potent telomere damage inducer. The change of LC3-II consistent with the change of γ-H2AX displayed a relationship between autophagy and telomere damage (Figs. 4 and 5) . It has previously been reported that in irradiated cells, autophagy develops in response to cell damage (46) . Therefore, SYUIQ-5-induced autophagy could be related to telomere DNA damage. The reduction of TRF2 was observed on protein levels but not mRNA levels in the exposure of SYUIQ-5 ( Fig. 2A and  B) . Double immunofluorescence showed that TRF2 delocalized from telomere after SYUIQ-5 treatment (Fig. 2D) . Combination with MG-132, a proteasome inhibitor, could prevent the reduction of TRF2 proteins. These results suggested that TRF2 was degraded by proteasome following delocalization from telomeres. However, the recovery of TRF2 proteins under MG132 combination cannot prevent the phosphorylation of H2AX (Fig. 2C) . TRF2 did not colocalize with SYUIQ-5-induced damaged telomeres, suggesting a causal relationship between the loss of TRF2 and the SYUIQ-5-induced telomere damage. The cancer cells treated with SYUIQ-5 may fold telomeres into G-quadruplex structures and propose a partial opening of the doublestrand telomere (47) . This structure seriously impacts the affinity of TRF2 binding to telomeres and gives an explanation of TRF2 delocalization. In any case, the removal of TRF2 is likely to be involved in the behavior of telomere damage provoked by the agent. Overexpression of wildtype TRF2 decreased the SYUIQ-5-induced γ-H2AX and LC3-II, and led cancer cells to become resistant to SYUIQ-5 (Fig. 4) . It might stabilize the telomeric T-loop and mask the overhang against SYUIQ-5 binding (3). The cancer cells expressing a mutant, TRF2
ΔBΔM , blocking the binding of TRF2 to the chromosome ends, were more sensitive to SYUIQ-5 exposure. These results further showed that the effects of SYUIQ-5 on cancer cells was directly associated with the instability of TRF2. It also suggested that the telomere is an important target of SYUIQ-5.
We further found that SYUIQ-5-induced H2AX phosphorylation depended on ATM activation. Combination with ATM siRNA or ku55633 (an ATM inhibitor) reduced the levels of ATM or ATM activity and the expression level of γ-H2AX (Fig. 5) . Since TRF2 was reported to be a specific inhibitor of ATM on telomeres and prevented inappropriate DNA repair at telomeres (48, 49) , these phenomena were probably caused by SYUIQ-5-induced TRF2 removal from telomeres.
In conclusion, the results from this study suggest that SYUIQ-5 can induce a potent telomere damage response, which mainly depends on TRF2 delocalization from telomeres, and eventually induces autophagic cell death in cancer cells. Our findings exhibit a novel mechanism that is responsible for SYUIQ-5-induced cell death.
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